Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M F Johnson

Showing results (71-80 of 82) with videos related to

Pageof 9
Sort By:
Cell Metabolism|June 9, 2015
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseEmma Börgeson, Andrew M F Johnson, Yun Sok Lee, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndromeShaocong Hou, Hengcai Yu, Caihong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Cell|November 5, 2016
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin ResistancePingping Li, Shuainan Liu, Min Lu, et al.
Diabetes|April 24, 2019
Microbiota-Produced <i>N</i>-Formyl Peptide fMLF Promotes Obesity-Induced Glucose IntoleranceJoshua Wollam, Matthew Riopel, Yong-Jiang Xu, et al.
Journal of Environmental Quality|November 13, 2013
Introducing the GRACEnet/REAP Data Contribution, Discovery, and Retrieval SystemS J Del Grosso, J W White, G Wilson, et al.
Journal of Environmental Quality|October 27, 2024
The LTAR Cropland Common Experiment at Upper Mississippi River Basin-AmesJohn L Kovar, Athanasios N Papanicolaou, Dennis L Busch, et al.
Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.
Pageof 9

Showing results (71-80 of 82) with videos related to

Sort By:
Pageof 9
Cell Metabolism|June 9, 2015
Lipoxin A4 Attenuates Obesity-Induced Adipose Inflammation and Associated Liver and Kidney DiseaseEmma Börgeson, Andrew M F Johnson, Yun Sok Lee, et al.
Acta Pharmaceutica Sinica. B|January 14, 2025
Intestinal epithelial cell NCoR deficiency ameliorates obesity and metabolic syndromeShaocong Hou, Hengcai Yu, Caihong Liu, et al.
Bioorganic & Medicinal Chemistry Letters|May 17, 2001
1,4-Benzodiazepine peripheral cholecystokinin (CCK-A) receptor agonistsR G Sherrill, J M Berman, L Birkemo, et al.
Journal of Medicinal Chemistry|July 19, 1996
3-[2-(N-phenylacetamide)]-1,5-benzodiazepines: orally active, binding selective CCK-A agonistsT M Willson, B R Henke, T M Momtahen, et al.
Journal of Medicinal Chemistry|December 20, 1996
Discovery of 1,5-benzodiazepines with peripheral cholecystokinin (CCK-A) receptor agonist activity (II): Optimization of the C3 amino substituentG C Hirst, C Aquino, L Birkemo, et al.
Cell|November 5, 2016
Hematopoietic-Derived Galectin-3 Causes Cellular and Systemic Insulin ResistancePingping Li, Shuainan Liu, Min Lu, et al.
Diabetes|April 24, 2019
Microbiota-Produced <i>N</i>-Formyl Peptide fMLF Promotes Obesity-Induced Glucose IntoleranceJoshua Wollam, Matthew Riopel, Yong-Jiang Xu, et al.
Journal of Environmental Quality|November 13, 2013
Introducing the GRACEnet/REAP Data Contribution, Discovery, and Retrieval SystemS J Del Grosso, J W White, G Wilson, et al.
Journal of Environmental Quality|October 27, 2024
The LTAR Cropland Common Experiment at Upper Mississippi River Basin-AmesJohn L Kovar, Athanasios N Papanicolaou, Dennis L Busch, et al.
Journal of Medicinal Chemistry|August 15, 1997
Optimization of 3-(1H-indazol-3-ylmethyl)-1,5-benzodiazepines as potent, orally active CCK-A agonistsB R Henke, C J Aquino, L S Birkemo, et al.
Pageof 9